Product
DWP712
1 clinical trial
1 indication
Indication
Frown LinesClinical trial
Double-blind, Randomized, Parallel Design, Active-controlled Phase 1 Clinical Trial to Evaluate the Efficacy and Safety of DWP712 and Botox® in Adult Patients in Need of Moderate to Severe Glabellar LinesStatus: Completed, Estimated PCD: 2024-02-26